Anixa Biosciences (ANIX) Q1 2026 Earnings
ANIX·Reported March 9, 2026·After market close
Diluted EPS came in at $-0.08 (+20.0% YoY), beat the $-0.09 consensus by $0.01.
Diluted EPS
$-0.08beat by $0.01
Consensus: $-0.09
Financial Snapshot
Trailing eight quarters through Q1 2026
Q1 2026 Earnings FAQ
Common questions about Anixa Biosciences's Q1 2026 earnings report.
Anixa Biosciences (ANIX) reported Q1 2026 earnings on March 9, 2026 after market close.
Anixa Biosciences reported diluted EPS of $-0.08 for Q1 2026.
EPS beat the consensus estimate of $-0.09 by $0.01.
Compared to the same quarter a year prior, diluted EPS grew 20.0% from $-0.10.
You can read the 8-K earnings release (0001493152-26-009699) and the 10-Q periodic report (0001493152-26-009370) directly on SEC EDGAR. The filing index links above go to sec.gov.